Clinical Trial Update: Renal Adjuvant MultiPle Arm Randomised Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial update for renal cell carcinoma in an adjuvant multi-arm study; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University College, London | Conditions: Renal Cell Carcinoma | Phase 3 | Status: RECRUITING